Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (311-320 of 351) with videos related to

Pageof 36
Sort By:
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2009
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodulesM Friedrich-Rust, A Sperber, K Holzer, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 20, 1999
Reduction of reperfusion injury with prostacyclin I2 after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Annals of Surgery|December 22, 1998
Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)M Lorenz, H H Müller, H Schramm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND StudyP TruneČka, J Klempnauer, W O Bechstein, et al.
Pageof 36

Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Transplantation Proceedings|March 27, 2001
Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allograftsS G Tullius, M Nieminen-Kelhä, U Bachmann, et al.
Transplantation Proceedings|September 2, 1998
Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantationM Glanemann, J M Langrehr, R Raakow, et al.
Transplantation Proceedings|September 2, 1998
Five-year follow-up of tacrolimus as primary immunosuppressant after liver transplantationS Jonas, O Guckelberger, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 1999
Successful recanalization of late portal vein thrombosis after liver transplantation using systemic low-dose recombinant tissue plasminogen activatorO Guckelberger, W O Bechstein, J M Langrehr, et al.
Transplantation Proceedings|September 2, 1998
Treatment with PGE1 in patients after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 27, 2009
Real-time elastography and contrast-enhanced ultrasound for the assessment of thyroid nodulesM Friedrich-Rust, A Sperber, K Holzer, et al.
Transplantation|June 27, 2000
Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trialP Neuhaus, J Klupp, J M Langrehr, et al.
Transplantation Proceedings|March 20, 1999
Reduction of reperfusion injury with prostacyclin I2 after liver transplantationU P Neumann, U Kaisers, J M Langrehr, et al.
Annals of Surgery|December 22, 1998
Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)M Lorenz, H H Müller, H Schramm, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2015
Renal Function in De Novo Liver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND StudyP TruneČka, J Klempnauer, W O Bechstein, et al.
Pageof 36